Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Invesco Dynamic Biotechnology & Genome ETF, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
Invesco Dynamic Biotechnology & Genome ETF (PBE) has returned -3.51% so far this year and 26.26% over the past 12 months. Over the last ten years, PBE has returned 7.52% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.
Invesco Dynamic Biotechnology & Genome ETF
- 1D
- 3.03%
- 1M
- -3.31%
- YTD
- -3.51%
- 6M
- 14.03%
- 1Y
- 26.26%
- 3Y*
- 8.51%
- 5Y*
- 1.51%
- 10Y*
- 7.52%
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
Based on dividend-adjusted daily data since Jun 23, 2005, PBE's average daily return is +0.05%, while the average monthly return is +0.88%. At this rate, your investment would double in approximately 6.6 years.
Historically, 56% of months were positive and 44% were negative. The best month was Jul 2008 with a return of +15.7%, while the worst month was Jan 2016 at -23.7%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 5 months.
On a daily basis, PBE closed higher 51% of trading days. The best single day was May 6, 2010 with a return of +34.8%, while the worst single day was May 7, 2010 at -31.2%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -0.34% | 0.13% | -3.31% | -3.51% | |||||||||
| 2025 | 4.26% | -3.82% | -4.86% | -1.83% | 0.53% | 2.59% | 1.87% | 4.82% | 2.41% | 7.10% | 11.35% | -0.91% | 24.84% |
| 2024 | -2.32% | 1.95% | -1.25% | -5.94% | 3.98% | 2.42% | 8.26% | 2.43% | -2.85% | -2.32% | 3.37% | -5.63% | 1.10% |
| 2023 | 5.17% | -4.73% | -1.34% | -0.28% | -3.67% | 1.66% | 3.53% | -2.98% | -7.35% | -6.04% | 9.34% | 12.36% | 3.71% |
| 2022 | -14.72% | -0.76% | 2.92% | -9.33% | 1.26% | 1.39% | 5.68% | -0.89% | -2.55% | 7.62% | 5.03% | -4.69% | -10.83% |
| 2021 | 7.92% | -2.00% | -0.47% | 2.17% | -2.92% | 5.61% | -2.50% | 4.10% | -4.65% | 0.31% | -6.10% | 1.03% | 1.54% |
Benchmark Metrics
Invesco Dynamic Biotechnology & Genome ETF has an annualized alpha of 2.91%, beta of 0.92, and R² of 0.42 versus S&P 500 Index. Calculated based on daily prices since June 24, 2005.
- R² of 0.42 means the benchmark explains less than half of this ETF's behavior — treat beta with caution or consider switching to a more representative benchmark.
- Alpha
- 2.91%
- Beta
- 0.92
- R²
- 0.42
- Upside Capture
- 103.77%
- Downside Capture
- 102.89%
Expense Ratio
PBE has an expense ratio of 0.59%, placing it in the medium range.
Return for Risk
Risk / Return Rank
PBE ranks 65 for risk / return — better than 65% of ETFs on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Invesco Dynamic Biotechnology & Genome ETF (PBE) and compare them to a chosen benchmark (S&P 500 Index).
| PBE | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.16 | 0.90 | +0.27 |
Sortino ratioReturn per unit of downside risk | 1.73 | 1.39 | +0.35 |
Omega ratioGain probability vs. loss probability | 1.22 | 1.21 | +0.01 |
Calmar ratioReturn relative to maximum drawdown | 2.12 | 1.40 | +0.72 |
Martin ratioReturn relative to average drawdown | 6.21 | 6.61 | -0.40 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Explore PBE risk-adjusted metrics in detail
Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.
Dividends
Dividend History
Invesco Dynamic Biotechnology & Genome ETF provided a 1.09% dividend yield over the last twelve months, with an annual payout of $0.87 per share. The fund has been increasing its distributions for 2 consecutive years.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.87 | $0.82 | $0.03 | $0.01 | $0.00 | $0.00 | $0.03 | $0.00 | $0.00 | $0.27 | $0.15 | $0.57 |
Dividend yield | 1.09% | 1.00% | 0.05% | 0.02% | 0.00% | 0.00% | 0.04% | 0.00% | 0.00% | 0.57% | 0.38% | 1.12% |
Monthly Dividends
The table displays the monthly dividend distributions for Invesco Dynamic Biotechnology & Genome ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.08 | $0.08 | |||||||||
| 2025 | $0.00 | $0.00 | $0.03 | $0.00 | $0.00 | $0.13 | $0.00 | $0.00 | $0.23 | $0.00 | $0.00 | $0.42 | $0.82 |
| 2024 | $0.00 | $0.00 | $0.02 | $0.00 | $0.00 | $0.01 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.03 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.01 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.01 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the Invesco Dynamic Biotechnology & Genome ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Invesco Dynamic Biotechnology & Genome ETF was 45.69%, occurring on Mar 9, 2009. Recovery took 293 trading sessions.
The current Invesco Dynamic Biotechnology & Genome ETF drawdown is 7.54%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -45.69% | Oct 16, 2007 | 351 | Mar 9, 2009 | 293 | May 6, 2010 | 644 |
| -44.56% | Jul 20, 2015 | 238 | Jun 27, 2016 | 1022 | Jul 20, 2020 | 1260 |
| -37.84% | Feb 9, 2021 | 340 | Jun 14, 2022 | 867 | Nov 26, 2025 | 1207 |
| -35.71% | May 7, 2010 | 41 | Jul 6, 2010 | 689 | Apr 2, 2013 | 730 |
| -21.12% | Feb 28, 2006 | 97 | Jul 17, 2006 | 192 | Apr 23, 2007 | 289 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...